Expression levels of CD133, a cancer stem cell marker, and of the α-subunit of the dystroglycan (α-DG) complex, have been previously reported to be altered in colorectal cancers.
Coco, C., Zannoni, G. F., Caredda, E., Sioletic, S., Boninsegna Lucarelli, A., Migaldi, M., Rizzo, G., Bonetti, L., Genovese, G., Stigliano, E., Cittadini, A. R. M., Sgambato, A., Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients, <<JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH>>, 2012; 31 (Settembre): 71-71. [doi:10.1186/1756-9966-31-71] [http://hdl.handle.net/10807/40235]
Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients
Coco, Claudio;Zannoni, Gian Franco;Caredda, Emanuele;Sioletic, Stefano;Boninsegna Lucarelli, Alma;Genovese, Giannicola;Stigliano, Egidio;Cittadini, Achille Renato Maria;Sgambato, Alessandro
2012
Abstract
Expression levels of CD133, a cancer stem cell marker, and of the α-subunit of the dystroglycan (α-DG) complex, have been previously reported to be altered in colorectal cancers.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
